Hsing‐Ju Wu

2.8k total citations
38 papers, 1.3k citations indexed

About

Hsing‐Ju Wu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Hsing‐Ju Wu has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Hsing‐Ju Wu's work include Bacterial Infections and Vaccines (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). Hsing‐Ju Wu is often cited by papers focused on Bacterial Infections and Vaccines (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). Hsing‐Ju Wu collaborates with scholars based in Taiwan, Australia and United States. Hsing‐Ju Wu's co-authors include Michael P. Jennings, Pei‐Yi Chu, Andrew H.‐J. Wang, Kate L. Seib, Michael A. Apicella, Alastair G. McEwan, Jennifer L. Edwards, Stephen P. Kidd, Tina L. Maguire and Sean M. Grimmond and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Hsing‐Ju Wu

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsing‐Ju Wu Taiwan 16 674 301 243 170 125 38 1.3k
Eun‐Young Lee South Korea 18 789 1.2× 508 1.7× 84 0.3× 207 1.2× 73 0.6× 34 1.6k
Maren Scharfe Germany 24 1.3k 1.9× 230 0.8× 169 0.7× 135 0.8× 290 2.3× 34 1.9k
Chee-Mun Fang Malaysia 17 824 1.2× 400 1.3× 131 0.5× 99 0.6× 65 0.5× 42 1.5k
Mark Cunningham United States 20 398 0.6× 233 0.8× 87 0.4× 83 0.5× 136 1.1× 29 1.3k
Gun Wook Park South Korea 15 715 1.1× 218 0.7× 118 0.5× 124 0.7× 58 0.5× 27 1.0k
Yaomei Tian China 20 831 1.2× 213 0.7× 49 0.2× 104 0.6× 256 2.0× 36 1.5k
Ming Zeng China 21 647 1.0× 59 0.2× 125 0.5× 106 0.6× 83 0.7× 71 1.1k
Thomas Bair United States 23 736 1.1× 118 0.4× 139 0.6× 206 1.2× 140 1.1× 35 1.4k

Countries citing papers authored by Hsing‐Ju Wu

Since Specialization
Citations

This map shows the geographic impact of Hsing‐Ju Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing‐Ju Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing‐Ju Wu more than expected).

Fields of papers citing papers by Hsing‐Ju Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsing‐Ju Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing‐Ju Wu. The network helps show where Hsing‐Ju Wu may publish in the future.

Co-authorship network of co-authors of Hsing‐Ju Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsing‐Ju Wu. A scholar is included among the top collaborators of Hsing‐Ju Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsing‐Ju Wu. Hsing‐Ju Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yu‐Chang, et al.. (2025). Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targeting the EGFR/NF‐κB Pathway and Immune Modulation. Journal of Cellular and Molecular Medicine. 29(16). e70699–e70699.
2.
Wu, Hsing‐Ju, et al.. (2023). Evaluating the Feasibility of a Deep Learning-Based Atypical Cell Gallery for Clinical Diagnosis in Urine Cytology. Journal of the American Society of Cytopathology. 12(5). S1–S2. 1 indexed citations
3.
Yang, Yuying, et al.. (2023). Investigating the Current Status of SARS-CoV-2 Antibodies in Hospital Staff. Pathogens. 12(5). 688–688.
4.
Lin, Hung‐Yu, Hsing‐Ju Wu, & Pei‐Yi Chu. (2023). Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer. Journal of Translational Medicine. 21(1). 189–189. 13 indexed citations
5.
Chang, Yu‐Chuan, et al.. (2023). Prenatal and early‐life antibiotic exposure and the risk of atopic dermatitis in children: A nationwide population‐based cohort study. Pediatric Allergy and Immunology. 34(5). e13959–e13959. 6 indexed citations
6.
Wu, Hsing‐Ju & Pei‐Yi Chu. (2022). Current and Developing Liquid Biopsy Techniques for Breast Cancer. Cancers. 14(9). 2052–2052. 35 indexed citations
7.
Chang, Cheng‐Chung, et al.. (2022). Investigation of Sonosensitizers Based on Phenothiazinium Photosensitizers. Applied Sciences. 12(15). 7819–7819. 5 indexed citations
8.
Lin, Yung-Kai, et al.. (2022). A New Biorecognition-Element-Free IDμE Sensor for the Identification and Quantification of E. coli. Biosensors. 12(8). 561–561. 4 indexed citations
9.
Wu, Hsing‐Ju, et al.. (2022). A Novel Role of Arrhythmia-Related Gene KCNQ1 Revealed by Multi-Omic Analysis: Theragnostic Value and Potential Mechanisms in Lung Adenocarcinoma. International Journal of Molecular Sciences. 23(4). 2279–2279. 10 indexed citations
10.
Lin, Hung‐Yu, Hsing‐Ju Wu, Siyun Chen, et al.. (2021). Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45A. Biomedicine & Pharmacotherapy. 145. 112431–112431. 10 indexed citations
11.
Huang, Shih‐Wei, Pei‐Yi Chu, Shun‐ichi Ariizumi, et al.. (2020). Anatomical Versus Non-anatomical Resection for Hepatocellular Carcinoma, a Propensity-matched Analysis Between Taiwanese and Japanese Patients. In Vivo. 34(5). 2607–2612. 5 indexed citations
12.
Yong, Su‐Boon, et al.. (2019). Impact of mycoplasma pneumonia infection on urticaria: A nationwide, population-based retrospective cohort study in Taiwan. PLoS ONE. 14(12). e0226759–e0226759. 4 indexed citations
13.
Yong, Su‐Boon, et al.. (2018). Impact of chronic urticaria on systemic lupus erythematosus: A nationwide population‐based study in Taiwan. The Journal of Dermatology. 46(1). 26–32. 8 indexed citations
14.
Wang, Hao‐Ching, et al.. (2012). Neisseria conserved protein DMP19 is a DNA mimic protein that prevents DNA binding to a hypothetical nitrogen-response transcription factor. Nucleic Acids Research. 40(12). 5718–5730. 24 indexed citations
15.
Wu, Hsing‐Ju, et al.. (2009). Structural Basis of α‐Fucosidase Inhibition by Iminocyclitols with Ki Values in the Micro‐ to Picomolar Range. Angewandte Chemie International Edition. 49(2). 337–340. 39 indexed citations
16.
Wu, Hsing‐Ju, Kate L. Seib, Yogitha N. Srikhanta, et al.. (2009). Manganese regulation of virulence factors and oxidative stress resistance in Neisseria gonorrhoeae. Journal of Proteomics. 73(5). 899–916. 32 indexed citations
17.
Wu, Hsing‐Ju, et al.. (2009). Structural Basis of α‐Fucosidase Inhibition by Iminocyclitols with Ki Values in the Micro‐ to Picomolar Range. Angewandte Chemie. 122(2). 347–350. 10 indexed citations
18.
Wu, Hsing‐Ju, Andrew H.‐J. Wang, & Michael P. Jennings. (2008). Discovery of virulence factors of pathogenic bacteria. Current Opinion in Chemical Biology. 12(1). 93–101. 197 indexed citations
19.
Wu, Hsing‐Ju, Kate L. Seib, Yogitha N. Srikhanta, et al.. (2006). PerR controls Mn‐dependent resistance to oxidative stress inNeisseria gonorrhoeae. Molecular Microbiology. 60(2). 401–416. 57 indexed citations
20.
Seib, Kate L., Mark P. Simons, Hsing‐Ju Wu, et al.. (2005). Investigation of Oxidative Stress Defenses of Neisseria gonorrhoeae by Using a Human Polymorphonuclear Leukocyte Survival Assay. Infection and Immunity. 73(8). 5269–5272. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026